European Union - English - EMA (European Medicines Agency)

endoceutics s.a. - prasterone - postmenopause - other sex hormones and modulators of the genital system - intrarosa is indicated for the treatment of vulvar and vaginal atrophy in postmenopausal women having moderate to severe symptoms.,

Israel - English - Ministry of Health

dexcel ltd, israel - prasterone - vaginal pessaries - prasterone 6.5 mg - prasterone - intrarosa is indicated for the treatment of vulvar and vaginal atrophy in postmenopausal women having moderate to severe symptoms.

United States - English - NLM (National Library of Medicine)

amag pharmaceuticals, inc. - prasterone (unii: 459ag36t1b) (prasterone - unii:459ag36t1b) - prasterone 6.5 mg - intrarosa® is a steroid indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. undiagnosed abnormal genital bleeding: any postmenopausal woman with undiagnosed, persistent or recurring genital bleeding should be evaluated to determine the cause of the bleeding before consideration of treatment with intrarosa. risk summary intrarosa is indicated only in postmenopausal women. there are no data with intrarosa use in pregnant women regarding any drug-associated risks. animal reproduction studies have not been conducted with prasterone. risk summary intrarosa is indicated only in postmenopausal women. there is no information on the presence of prasterone in human milk, the effects on the breastfed infant, or the effects on milk production. safety and effectiveness have not been established in pediatric patients. of the 1522 prasterone-treated postmenopausal women enrolled in the four placebo-controlled 12-week and one open-label 52-week clinical t

Canada - English - Health Canada

cosette pharmaceuticals, inc. - prasterone - ovule - 6.5mg - prasterone 6.5mg - androgens

United States - English - NLM (National Library of Medicine)

millicent us, inc. - prasterone (unii: 459ag36t1b) (prasterone - unii:459ag36t1b) - intrarosa ® is a steroid indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. undiagnosed abnormal genital bleeding: any postmenopausal woman with undiagnosed, persistent or recurring genital bleeding should be evaluated to determine the cause of the bleeding before consideration of treatment with intrarosa. risk summary intrarosa is indicated only in postmenopausal women. there are no data with intrarosa use in pregnant women regarding any drug-associated risks. animal reproduction studies have not been conducted with prasterone. risk summary intrarosa is indicated only in postmenopausal women. there is no information on the presence of prasterone in human milk, the effects on the breastfed infant, or the effects on milk production. safety and effectiveness have not been established in pediatric patients. of the 1522 prasterone-treated postmenopausal women enrolled in the four placebo-controlled 12-week and one open-label 52-week clinic

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer sa-nv - dinoprostone 0,5 mg/3 g - endocervical gel - 0,5 mg - 3 g - dinoprostone 0.5 mg - dinoprostone

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

cepheid, u.s.a - vaginal endocervical specimen collection kit -

Singapore - English - HSA (Health Sciences Authority)

ehc commercial singapore pte. ltd. - dental - the cordless elements ic obturation system is intended to be used in endodontics to backfill and downpack gutta-percha during root canal obturation using warm vertical obturation technique

Singapore - English - HSA (Health Sciences Authority)

henry schein pte ltd - dental - gutta percha points are root canal obturation material. it is used to fill the cleaned, shaped and irrigated root canal space

Singapore - English - HSA (Health Sciences Authority)

henry schein pte ltd - dental - paper points are used to dry the root canal before obturation and to clean the root canals that are to be sealed in endodontic treatments.